These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9844883)

  • 1. [The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].
    Tashchuk VK; Polishchuk OIu; Hrechko SI; Makoviĭchuk IO; Polians'ka OS; Turubarova NA; Chaplyns'kyĭ RB; Sokur IV
    Lik Sprava; 1998 Aug; (6):84-6. PubMed ID: 9844883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 3. Recognition, diagnosis, and prognosis of early reinfarction: the role of calcium-channel blockers.
    Roberts R
    Circulation; 1987 Jun; 75(6 Pt 2):V139-47. PubMed ID: 2882872
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects on isolated hearts with developing infarction: slow channel blockade by diltiazem versus beta-adrenoceptor antagonism by metoprolol.
    Hamm CW; Thandroyen FT; Opie LH
    Am J Cardiol; 1982 Oct; 50(4):857-63. PubMed ID: 6127029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the anti-angina effect of the calcium antagonists diltiazem, nifedipine and verapamil with each other and with propranolol].
    Ferrero JA; Asensi JF; Madrigal JA; Haba J; Chorro FJ; López Merino V
    Rev Esp Cardiol; 1987; 40(4):249-55. PubMed ID: 3659517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?].
    Ennezat PV; Auffray JL; Darchis J; Rousselle M; Gonin X; Aubert JM; Bauchart JJ; Bauters C; Van Belle E; Asseman P
    Therapie; 2006; 61(3):191-4. PubMed ID: 16989118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the action of beta-blockers and calcium inhibitors in the treatment of primary angina pectoris].
    Bory M; Bénichou M
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():153-9. PubMed ID: 6134506
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent concepts in the management of ischaemic cardiac syndromes.
    Valentine PA; Sutton LD; Sloman JG
    Aust Fam Physician; 1982 Jan; 11(1):23-34. PubMed ID: 6121552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of immediate exercise treadmill testing in patients taking beta blockers or calcium channel blockers.
    Diercks DB; Kirk JD; Turnipseed SD; Amsterdam EA
    Am J Cardiol; 2002 Oct; 90(8):882-5. PubMed ID: 12372580
    [No Abstract]   [Full Text] [Related]  

  • 12. Value and limitations of provocative testing to assess the efficacy of treatment in variant angina.
    Waters DD
    Cardiovasc Clin; 1983; 14(1):87-98. PubMed ID: 6352031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of verapamil vs. beta blockers in patients with myocardial infarct. Retrospective evaluation of the yearly case load of a coronary care unit].
    Rubboli A; Colletta M; Sangiorgio P; Casella G; Pavesi PC; Bracchetti D
    Minerva Cardioangiol; 1997; 45(7-8):349-56. PubMed ID: 9463170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockers in the management of myocardial infarction patients.
    Gheorghiade M
    Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.